Operating income on consolidated basis increased by 38.10% at Rs 44.58 crore in Q4 FY25
QMS Medical Allied Services, a leading holistic healthcare management solutions company, registered 134.36 per cent growth in net profit on a consolidated basis at Rs 3.61 crore during the quarter ended March 31, 2025, as compared with Rs 1.54 crore same period last year as a result of higher revenues and improved demand.
Operating income on a consolidated basis was at Rs 44.58 crore for the quarter under review as against Rs 32.29 crore same period last year.
For the full year ended March 31, 2025, the company registered 52.16 per cent growth in net profit on a consolidated basis at Rs 13.70 crore as compared with Rs 9.00 crore same period last year. Operating income increased by 27.75 per cent at Rs 156.01 crore in 2024-25 as against Rs 122.13 crore last year.
EBITDA was at Rs 6.38 crore for the quarter and Rs 25.41 crore for the full year ended March 31, 2025, a 61.51 per cent and 38.49 per cent increase from the same periods last year respectively.
The company had earlier in FY25 acquired 51 per cent stake in Saarathi Healthcare - a pioneer in patient and disease management services, market access, and phygital solutions which helped bolster its topline giving a boost to its business. The company had also forayed into a new business segment of distributing hospital supplies by entering into tie up with various hospitals in nationwide.
Commenting on the company’s performance during the quarter and full year, Mahesh Makhija, Founder, Chairman & Managing Director, QMS Medical Allied Services Limited, said, “We have been witnessing a consistent growth in our topline backed by our sustained efforts to grow our core business and also foray into newer business verticals and geographies. Our acquisition of majority stake in Saarathi Healthcare, which has managed over 1000 projects and has developed partnerships with over 60 enterprise clients in the last 15 years, has augured well for our company. We believe there is a huge potential to grow our customised patient service/outreach programmes across the country. We have also implemented sustained cost-reduction strategies which has helped boost our margins.”
“We expect the growth momentum to sustain in the coming quarters and our overall performance to witness a robust growth in FY26,” he added.
Subscribe To Our Newsletter & Stay Updated